327 related articles for article (PubMed ID: 27650934)
21. Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma in the Caudate Lobe.
Dou JP; Yu J; Cheng ZG; Han ZY; Liu FY; Yu XL; Liang P
Ultrasound Med Biol; 2016 Aug; 42(8):1825-33. PubMed ID: 27126238
[TBL] [Abstract][Full Text] [Related]
22. US-guided percutanous microwave ablation for early-stage hepatocellular carcinoma in elderly patients is as effective as in younger patients: A 10-year experience.
Wang Y; Cheng Z; Yu J; Li X; Hao G; Liu F; Han Z; Yu X; Liang P
J Cancer Res Ther; 2020; 16(2):292-300. PubMed ID: 32474516
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic Microwave Ablation of Hepatocellular Carcinoma at Liver Surface: Technique Effectiveness and Long-Term Outcomes.
Wang T; Zhang XY; Lu X; Zhai B
Technol Cancer Res Treat; 2019 Jan; 18():1533033818824338. PubMed ID: 30803390
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous microwave ablation of exophytic tumours in hepatocellular carcinoma patients: Safe or not?
Ding J; Zhou Y; Wang Y; Jing X; Wang F; Wang Y
Liver Int; 2017 Sep; 37(9):1365-1372. PubMed ID: 28319345
[TBL] [Abstract][Full Text] [Related]
25. MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
Li Z; Wang C; Li J; Liu Z; Jiao D; Han X
BMC Cancer; 2021 May; 21(1):562. PubMed ID: 34001036
[TBL] [Abstract][Full Text] [Related]
26. Different power modes of microwave ablation for hepatocellular carcinoma: Evaluation of recurrence rate and factors related to recurrence.
Dong T; Nie F; Liu T; Wang L; Yang D; Yan X
Asian J Surg; 2023 Sep; 46(9):3520-3528. PubMed ID: 37002048
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients.
Liu S; Zhou P; Shen Q; Qian G
J Cancer Res Ther; 2024 Apr; 20(2):547-554. PubMed ID: 38687924
[TBL] [Abstract][Full Text] [Related]
28. Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes.
Yu SC; Hui EP; Tang P; Chan SK; Chu CC; Hui JW; Chan SL; Lee KF; Lai PB; Yeo W
J Vasc Interv Radiol; 2016 May; 27(5):639-49. PubMed ID: 26803574
[TBL] [Abstract][Full Text] [Related]
29. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation.
Xu HX; Xie XY; Lu MD; Chen JW; Yin XY; Xu ZF; Liu GJ
Clin Radiol; 2004 Jan; 59(1):53-61. PubMed ID: 14697375
[TBL] [Abstract][Full Text] [Related]
33. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC.
Zhang J; Guo G; Li T; Guo C; Han Y; Zhou X
Int J Hyperthermia; 2024; 41(1):2318829. PubMed ID: 38467417
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
[No Abstract] [Full Text] [Related]
36. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus may worsen the prognosis in hepatocellular carcinoma patients undergoing curative microwave ablation.
Liu SR; Chao R; Liang P; Yu XL; Cheng ZG; Han ZY
J BUON; 2018; 23(4):958-964. PubMed ID: 30358199
[TBL] [Abstract][Full Text] [Related]
38. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of long-term therapeutic effects of ultrasound-guided percutaneous microwave ablation of liver metastases].
Liang P; Dong BW; Yu XL; Yu DJ; Feng L; Gao YY; Wang Y; Xiao QJ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):806-10. PubMed ID: 16681966
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous Microwave Ablation Under CT Guidance for Hepatocellular Carcinoma: a Single Institutional Experience.
Pusceddu C; Melis L; Ballicu N; Sotgia B; Melis M; Sanna V; Meloni GB; Porcu A; Fancellu A
J Gastrointest Cancer; 2018 Sep; 49(3):295-301. PubMed ID: 28530021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
